Related Experiment Videos
[Immune status of patients with different outcomes of acute hepatitis C]
Insights
A high count of O-lymphocytes in acute hepatitis C patients may signal progression to chronic hepatitis C. This immune marker aids in predicting disease outcomes for hepatitis C patients.
Area of Science:
- Immunology
- Hepatology
- Virology
Context:
- Hepatitis C is a significant global health concern.
- Understanding immune responses in acute hepatitis C (AHC) is crucial for predicting disease progression.
- Differentiating between acute and chronic hepatitis C (CHC) is vital for effective patient management.
Purpose:
- To identify immune response parameters predictive of disease outcomes in patients with AHC.
- To compare immune cell populations in patients with AHC, CHC, and healthy controls.
- To investigate the role of lymphocyte subpopulations in the transition from AHC to CHC.
Summary:
- The study analyzed immune status in 72 participants, including AHC patients, CHC patients, AHC convalescents, and healthy controls.
- A higher absolute count of O-lymphocytes during the acute phase of hepatitis C was associated with a higher likelihood of developing chronic hepatitis C.
- Elevated levels of CD3+, CD4+, and HLA-DR+CD3+ lymphocytes were observed in both AHC convalescents and patients who developed CHC, as well as in those with established CHC.
Impact:
- This research provides a potential biomarker for early identification of patients at risk of developing chronic hepatitis C.
- Findings can inform clinical decisions regarding monitoring and treatment strategies for hepatitis C.
- Contributes to a deeper understanding of the immunopathogenesis of hepatitis C virus infection.
Aim:
To ascertain parameters of immune response significant for prognosis of the disease outcome in patients with acute hepatitis C (AHC).
Material And Methods:
Seventy two examinees were divided into three groups: 30 patients of group 1 had AHC; 29 patients of group 2 had chronic hepatitis C (CHC) with the disease history 3-10 years; 13 AHC convalescents who had the disease 3-10 years ago. The control group consisted of 10 healthy subjects. The following parameters of immune status were studied: CD3+, CD4+, CD8+, CD16+, CD20+, HLA-DR+CD3+, CD95+, O-lymphocytes.
Results:
By clinicobiochemical picture and the results of 12-month follow-up RT-PCR investigations of blood HCV RNA, AHC patients were divided into two groups: in 18 (72%) of 25 patients AHC became chronic, 7 (28%) patients achieved convalescence. The proportion and absolute number of subpopulations of lymphocytes CD8+, CD20+, CD16+ as well as CD4/CD8 in patients with AHC with different outcomes did not differ from the controls. AHC convalescents and patients with AHC transformation into chronic hepatitis had in the acute period of the disease much higher absolute number of subpopulations of the lymphocytes CD3+, CD4+, HLA-DR+CD3+ vs the controls. In patients with chronic hepatitis C with elevated levels of AlAT, 3-10 year follow-up registered significantly higher absolute amount of CD8+, CD3+, CD4+, HLA-DR+CD3+ vs the controls. Only patients with AHC which later became chronic had for 6 months of the disease significantly elevated absolute number of O-lymphocytes vs the controls.
Conclusion:
A high absolute count of O-lymphocytes in AHC patients may indicate probable development of chronic hepatitis C.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction